# 21 C.F.R. § 355.55 (2026): Principal display panel of all fluoride rinse drug products

> Federal · Regulations · In force

URL: https://www.frixlaw.com/law-library/statutes/CFR_T21_P355_S355_55

## Section

- **Citation:** 21 C.F.R. § 355.55 (2026)
- **Heading:** Principal display panel of all fluoride rinse drug products
- **Jurisdiction:** Federal
- **Kind:** Regulations
- **Status:** In force
- **Text as of:** August 14, 2026
- **Source:** Compiled text
- **Location:** Title 21 CFR: Food and Drugs / Chapter I: FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES / Part 355: ANTICARIES DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE / Subpart C: Labeling / § 355.55: § 355.55   Principal display panel of all fluoride rinse drug products.

## Text

In addition to the statement of identity required in § 355.50, the following statement shall be prominently placed on the principal display panel: “IMPORTANT: Read directions for proper use.”

## Nearby sections

- [21 C.F.R. § 355.50 (2026) § 355.50   Labeling of anticaries drug products.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P355_S355_50.md)
- [21 C.F.R. § 355.55 (2026) § 355.55   Principal display panel of all fluoride rinse drug products.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P355_S355_55.md)
- [21 C.F.R. § 355.60 (2026) § 355.60   Professional labeling.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P355_S355_60.md)

---

Source: Frix Law Library, https://www.frixlaw.com/law-library/statutes/CFR_T21_P355_S355_55. Check the current official text before relying on it. Not legal advice.